United States Intramuscular Immune Globulin Market Report 2018

April 2018 | 102 pages | ID: U8EFEDCF6E3EN
QYResearch

Abstracts

In this report, the United States Intramuscular Immune Globulin market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Intramuscular Immune Globulin in these regions, from 2013 to 2025 (forecast).

United States Intramuscular Immune Globulin market competition by top manufacturers/players, with Intramuscular Immune Globulin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Grifols Therapeutics

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• 10mL Vial
• 2.0mL Vial

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hepatitis A
• Measles
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Intramuscular Immune Globulin Market Report 2018

1 INTRAMUSCULAR IMMUNE GLOBULIN OVERVIEW

1.1 Product Overview and Scope of Intramuscular Immune Globulin
1.2 Classification of Intramuscular Immune Globulin by Product Category
  1.2.1 United States Intramuscular Immune Globulin Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Intramuscular Immune Globulin Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 10mL Vial
  1.2.4 2.0mL Vial
1.3 United States Intramuscular Immune Globulin Market by Application/End Users
  1.3.1 United States Intramuscular Immune Globulin Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hepatitis A
  1.3.3 Measles
  1.3.4 Others
1.4 United States Intramuscular Immune Globulin Market by Region
  1.4.1 United States Intramuscular Immune Globulin Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Intramuscular Immune Globulin Status and Prospect (2013-2025)
  1.4.3 Southwest Intramuscular Immune Globulin Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Intramuscular Immune Globulin Status and Prospect (2013-2025)
  1.4.5 New England Intramuscular Immune Globulin Status and Prospect (2013-2025)
  1.4.6 The South Intramuscular Immune Globulin Status and Prospect (2013-2025)
  1.4.7 The Midwest Intramuscular Immune Globulin Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Intramuscular Immune Globulin (2013-2025)
  1.5.1 United States Intramuscular Immune Globulin Sales and Growth Rate (2013-2025)
  1.5.2 United States Intramuscular Immune Globulin Revenue and Growth Rate (2013-2025)

2 UNITED STATES INTRAMUSCULAR IMMUNE GLOBULIN MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Intramuscular Immune Globulin Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Intramuscular Immune Globulin Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Intramuscular Immune Globulin Average Price by Players/Suppliers (2013-2018)
2.4 United States Intramuscular Immune Globulin Market Competitive Situation and Trends
  2.4.1 United States Intramuscular Immune Globulin Market Concentration Rate
  2.4.2 United States Intramuscular Immune Globulin Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Intramuscular Immune Globulin Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES INTRAMUSCULAR IMMUNE GLOBULIN SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Intramuscular Immune Globulin Sales and Market Share by Region (2013-2018)
3.2 United States Intramuscular Immune Globulin Revenue and Market Share by Region (2013-2018)
3.3 United States Intramuscular Immune Globulin Price by Region (2013-2018)

4 UNITED STATES INTRAMUSCULAR IMMUNE GLOBULIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Intramuscular Immune Globulin Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Intramuscular Immune Globulin Revenue and Market Share by Type (2013-2018)
4.3 United States Intramuscular Immune Globulin Price by Type (2013-2018)
4.4 United States Intramuscular Immune Globulin Sales Growth Rate by Type (2013-2018)

5 UNITED STATES INTRAMUSCULAR IMMUNE GLOBULIN SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Intramuscular Immune Globulin Sales and Market Share by Application (2013-2018)
5.2 United States Intramuscular Immune Globulin Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES INTRAMUSCULAR IMMUNE GLOBULIN PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Grifols Therapeutics
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Intramuscular Immune Globulin Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Grifols Therapeutics Intramuscular Immune Globulin Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview

7 INTRAMUSCULAR IMMUNE GLOBULIN MANUFACTURING COST ANALYSIS

7.1 Intramuscular Immune Globulin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Intramuscular Immune Globulin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Intramuscular Immune Globulin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Intramuscular Immune Globulin Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES INTRAMUSCULAR IMMUNE GLOBULIN MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Intramuscular Immune Globulin Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Intramuscular Immune Globulin Sales Volume Forecast by Type (2018-2025)
11.3 United States Intramuscular Immune Globulin Sales Volume Forecast by Application (2018-2025)
11.4 United States Intramuscular Immune Globulin Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Intramuscular Immune Globulin
Figure United States Intramuscular Immune Globulin Market Size (K Units) by Type (2013-2025)
Figure United States Intramuscular Immune Globulin Sales Volume Market Share by Type (Product Category) in 2017
Figure 10mL Vial Product Picture
Figure 2.0mL Vial Product Picture
Figure United States Intramuscular Immune Globulin Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Intramuscular Immune Globulin by Application in 2017
Figure Hepatitis A Examples
Table Key Downstream Customer in Hepatitis A
Figure Measles Examples
Table Key Downstream Customer in Measles
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Intramuscular Immune Globulin Market Size (Million USD) by Region (2013-2025)
Figure The West Intramuscular Immune Globulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Intramuscular Immune Globulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Intramuscular Immune Globulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Intramuscular Immune Globulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Intramuscular Immune Globulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Intramuscular Immune Globulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Intramuscular Immune Globulin Sales (K Units) and Growth Rate (2013-2025)
Figure United States Intramuscular Immune Globulin Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Intramuscular Immune Globulin Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Intramuscular Immune Globulin Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Intramuscular Immune Globulin Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Intramuscular Immune Globulin Sales Share by Players/Suppliers
Figure 2017 United States Intramuscular Immune Globulin Sales Share by Players/Suppliers
Figure United States Intramuscular Immune Globulin Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Intramuscular Immune Globulin Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Intramuscular Immune Globulin Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Intramuscular Immune Globulin Revenue Share by Players/Suppliers
Figure 2017 United States Intramuscular Immune Globulin Revenue Share by Players/Suppliers
Table United States Market Intramuscular Immune Globulin Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Intramuscular Immune Globulin Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Intramuscular Immune Globulin Market Share of Top 3 Players/Suppliers
Figure United States Intramuscular Immune Globulin Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Intramuscular Immune Globulin Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Intramuscular Immune Globulin Product Category
Table United States Intramuscular Immune Globulin Sales (K Units) by Region (2013-2018)
Table United States Intramuscular Immune Globulin Sales Share by Region (2013-2018)
Figure United States Intramuscular Immune Globulin Sales Share by Region (2013-2018)
Figure United States Intramuscular Immune Globulin Sales Market Share by Region in 2017
Table United States Intramuscular Immune Globulin Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Intramuscular Immune Globulin Revenue Share by Region (2013-2018)
Figure United States Intramuscular Immune Globulin Revenue Market Share by Region (2013-2018)
Figure United States Intramuscular Immune Globulin Revenue Market Share by Region in 2017
Table United States Intramuscular Immune Globulin Price (USD/Unit) by Region (2013-2018)
Table United States Intramuscular Immune Globulin Sales (K Units) by Type (2013-2018)
Table United States Intramuscular Immune Globulin Sales Share by Type (2013-2018)
Figure United States Intramuscular Immune Globulin Sales Share by Type (2013-2018)
Figure United States Intramuscular Immune Globulin Sales Market Share by Type in 2017
Table United States Intramuscular Immune Globulin Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Intramuscular Immune Globulin Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Intramuscular Immune Globulin by Type (2013-2018)
Figure Revenue Market Share of Intramuscular Immune Globulin by Type in 2017
Table United States Intramuscular Immune Globulin Price (USD/Unit) by Types (2013-2018)
Figure United States Intramuscular Immune Globulin Sales Growth Rate by Type (2013-2018)
Table United States Intramuscular Immune Globulin Sales (K Units) by Application (2013-2018)
Table United States Intramuscular Immune Globulin Sales Market Share by Application (2013-2018)
Figure United States Intramuscular Immune Globulin Sales Market Share by Application (2013-2018)
Figure United States Intramuscular Immune Globulin Sales Market Share by Application in 2017
Table United States Intramuscular Immune Globulin Sales Growth Rate by Application (2013-2018)
Figure United States Intramuscular Immune Globulin Sales Growth Rate by Application (2013-2018)
Table Grifols Therapeutics Basic Information List
Table Grifols Therapeutics Intramuscular Immune Globulin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Grifols Therapeutics Intramuscular Immune Globulin Sales Growth Rate (2013-2018)
Figure Grifols Therapeutics Intramuscular Immune Globulin Sales Market Share in United States (2013-2018)
Figure Grifols Therapeutics Intramuscular Immune Globulin Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Intramuscular Immune Globulin
Figure Manufacturing Process Analysis of Intramuscular Immune Globulin
Figure Intramuscular Immune Globulin Industrial Chain Analysis
Table Raw Materials Sources of Intramuscular Immune Globulin Major Players/Suppliers in 2017
Table Major Buyers of Intramuscular Immune Globulin
Table Distributors/Traders List
Figure United States Intramuscular Immune Globulin Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Intramuscular Immune Globulin Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Intramuscular Immune Globulin Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Intramuscular Immune Globulin Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Intramuscular Immune Globulin Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Intramuscular Immune Globulin Sales Volume (K Units) Forecast by Type in 2025
Table United States Intramuscular Immune Globulin Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Intramuscular Immune Globulin Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Intramuscular Immune Globulin Sales Volume (K Units) Forecast by Application in 2025
Table United States Intramuscular Immune Globulin Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Intramuscular Immune Globulin Sales Volume Share Forecast by Region (2018-2025)
Figure United States Intramuscular Immune Globulin Sales Volume Share Forecast by Region (2018-2025)
Figure United States Intramuscular Immune Globulin Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources